West German Proton Therapy Centre Essen, Am Mühlenbach 1, 45147 Essen, Germany; University Hospital Essen, Hufelandstr. 55, Essen, Germany; West German Cancer Center (WTZ), Hufelandstr. 55, Essen, Germany; Technische Universität Dortmund, Otto-Hahn-Str. 4a, 44227 Dortmund, Germany.
West German Proton Therapy Centre Essen, Am Mühlenbach 1, 45147 Essen, Germany; University Hospital Essen, Hufelandstr. 55, Essen, Germany; West German Cancer Center (WTZ), Hufelandstr. 55, Essen, Germany; Technische Universität Dortmund, Otto-Hahn-Str. 4a, 44227 Dortmund, Germany; German Cancer Consortium (DKTK), Germany.
Z Med Phys. 2022 Feb;32(1):63-73. doi: 10.1016/j.zemedi.2020.08.001. Epub 2020 Oct 31.
Proton fields delivered by the active scanning technique can be interfered with the intrafractional motion. This in-silico study seeks to mitigate the dosimetric impacts of motion artifacts, especially its interplay with the time-modulated dose delivery. Here four-dimensional (4d) robust optimization and dose repainting, which is the multiple application of the same field with reduced fluence, were combined. Two types of repainting were considered: layered and volumetric repainting. The time-resolved dose calculation, which is necessary to quantify the interplay effect, was integrated into the treatment planning system and validated. Nine clinical cases of hepatocellular carcinoma (HCC) showing motion in the range of 0.4-1.5cm were studied. It was found that the repainted delivery of 4D robustly optimized plans reduced the impact of interplay effect as quantified by the homogeneity index within the clinical target volume (CTV) to a tolerable level. Similarly, the fractional over- and underdosage was reduced sufficiently for some HCC cases to achieve the purpose of motion management. This holds true for both investigated types of repainting with small dosimetric advantages of volume repainting over layered repainting. Volume repainting, however, cannot be applied clinically in proton centers with slow energy changes. Thus, it served as a reference in the in-silico evaluation. It is recommended to perform the dynamic dose calculation for individual cases to judge if robust optimization in conjunction with repainting is sufficient to keep the interplay effect within bounds.
质子射束的主动扫描技术可能会受到分次内运动的干扰。本数值研究旨在减轻运动伪影的剂量学影响,特别是其与时间调制剂量输送的相互作用。在此,将四维(4D)稳健优化和剂量重绘(即减少通量的相同场的多次应用)相结合。考虑了两种重绘类型:分层和体积重绘。为了量化相互作用效应,需要进行时间分辨剂量计算,已将其集成到治疗计划系统中并进行了验证。研究了 9 个显示 0.4-1.5cm 运动范围的肝细胞癌(HCC)的临床病例。结果发现,通过 4D 稳健优化计划的重绘传输,将临床靶体积(CTV)内的均匀性指数所量化的相互作用效应的影响降低到可接受的水平。同样,对于某些 HCC 病例,过剂量和欠剂量的分数也降低到足以达到运动管理的目的。这两种所研究的重绘类型都适用,体积重绘相对于分层重绘具有较小的剂量学优势。然而,在能量变化缓慢的质子中心,无法在临床上应用体积重绘。因此,它在数值评估中仅作为参考。建议对个别病例进行动态剂量计算,以判断是否可以通过稳健优化和重绘来控制相互作用效应。